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Clinical analysis of the corona phlebectatica
Jean-François Uhl, MD,a André Cornu-Thenard, MD,b Bernadette Satger, MD,c and
Patrick H. Carpentier, MD,c Paris and Grenoble, France
Background: The corona phlebectatica (CP) is classically described as the presence of abnormally visible cutaneous blood
vessels at the ankle with four components: “venous cups,” blue and red telangiectases, and capillary “stasis spots.”
Previous studies showed that the presence of CP is strongly related to the clinical severity of chronic venous disorders
(CVD) and the presence of incompetent leg perforators. The aim of this study was to select the most informative
components of the CP in the assessment of the clinical severity of CVD patients.
Methods: A multicentric series of 262 unselected patients (524 limbs) consulted for CVD were clinically evaluated using
a standardized form to record the CEAP “C” items and the presence of the four CP components. Standard categorical and
ordinal statistics were used to describe the external validity of the CP components as severity indexes, taking the “C”
classes as reference.
Results: “Stasis spots” (P < .001; r  .44) and blue telangiectases (P < .01; r  .32) were linearly associated with the
ascending order of “C” classes, whereas the relationship is less clear for the red telangiectases and the “venous cups.” The
association pattern of the four components showed that only the blue telangiectases and the “stasis spots” were consistent
with each other. Blue telangiectases were found more sensitive (0.91 vs 0.75) but less specific (0.52 vs 0.80) than “stasis
spots” for advanced venous insufficiency (CEAP “C4-6”).
Conclusion: This study shows that only blue telangiectases and “stasis spots” provide valuable information in patients
with CVD and deserve to be taken into account in the evaluation of such patients. Further studies are needed to show the
reproducibility of this data, which we regard as essential for clinical use. ( J Vasc Surg 2012;55:150-3.)
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dThe corona phlebectatica (CP) is defined as a “fan-
shaped intradermal telangiectases on the medial or lateral
aspects of the foot.”1 It was first described in 1960 by H.R.
van der Molen2,3,4 as the association of four components:
Telangiectases are dilated ramified intradermal venules lo-
cated at the medial and/or and lateral aspects of the foot,
next to the malleolar areas; they can be classified as blue
(Fig 1, a) or red (Fig 1, b). “Venous cups” (Fig 1, c) extend
to the plantar arch as six to eight blue cups, and are
secondary to the dilatation of the triangular shaped venous
convergences coming from the plantar arch. Finally, “stasis
spots” are composed of subepidermal papillary capillaries
grouped into nummular or coin-shaped red or purple col-
ored areas (Fig 1, d).
The CP was used by LeoWidmer, in the Basle study, as
the definition for the first grade of “Chronic Venous Insuf-
ficiency,”5 as well as in the subsequent literature that used
the Widmer classification.5,6
We previously found a significant correlation between
the presence of a CP and the ascending severity “C” classes
of the CEAP classification.7 A significant link was also
demonstrated between the CP and the presence of incom-
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150etent perforators in the calf or lower leg,8 and its predic-
ive value for the future occurrence of leg ulcers, as was also
hown.9
The aim of this particular study was to describe the
ssociation pattern and clinical correlation of the four com-
onents of CP in CVD patients, in order to document
hich of these components could be relevant for the clini-
al evaluation of the severity in CVD patients.
ETHODS
Between March and September 2006, a cooperative
roup of 10 vascular physicians recorded specific clinical
nformation regarding the CP in addition to their usual
linical evaluation in patients aged 18 years or more seeking
edical care for CVD and presenting visible cutaneous
lood vessels in the submalleolar area of at least one leg. No
bligation was made to include a consecutive series of
atients, but a full completion of the record sheet was
equired. The record sheet included examination date,
irth date, and full documentation of the “C” components
f the CEAP, as well as the four components of the CP:
elangiectases, “venous cups,” blue cups, and “stasis
pots” (Fig 1).
The statistical analysis was performed with SPSS soft-
are (14.0 version; SPSS, Chicago, IL), using standard
escriptive statistics, Fischer exact tests (two-tailed) and
pearman rank correlations were used to evaluate the rela-
ionship between each component and the CEAP “C”
linical classes, and with advanced venous insufficiency,
efined as CEAP C4 to C6. A P value 0.05 was consid-
red significant.
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The series consisted of 262 patients with clinical data
recorded from June 1, 2006 to September 10, 2006. There
were 216 women (82.4%) and 46 men (17.6%), with a
median age of 55 years (Interquartile range, 46-64) and 64
years (Interquartile range, 54-74), respectively. The post-
thrombotic syndrome was present in 10.6% of the women
and in 6.3% of the men.
The majority of limbs examined were classified C1 or
C2 (65%) according to the CEAP classification. Limbs
without any sign of CVD (C0 1.7%) were included be-
cause of the systematic examination of both limbs, includ-
ing the unilateral CVD (Table I).
The correlation study of each of the four corona com-
ponents with the ascending CEAP “C” classes showed no
significant relationship for the cupular veins and the red
telangiectases (Fig 2), but a significant relationship for blue
telangiectases (P  .01; r  .32) and “stasis spots” (P 
.001; r  .44; Fig 3). The study of the sensitivity and
specificity of the four components for the diagnosis of
advanced venous insufficiency (CEAP C4-C6) shows again
(Table II) that the “stasis spots” and blue telangiectases
have the highest likelihood ratio. Blue telangiectases are
Fig 1. The four components of the corona (clinical aspect). (a)
Venous cups (veins); (b) Blue telangiectases (intradermal venules);
(c) Red telangiectases (superficial venules); (d) Stasis spots
(capillaries).
Table I. Distribution of the clinical “C” CEAP classes of
the 524 limbs examined
CEAP “C” classes Limbs (n  524) %
C0 9 1.7
C1 170 32.4
C2 222 42.4
C3 67 12.8
C4a 27 5.2
C4b 14 2.7
C5 12 2.3
C6 3 0.6more sensitive than stasis spots (0.91 vs 0.75) but less specific (0.52 vs 0.80) for the prediction of skin changes
C4 to C6). Red telangiectases and cupular veins show
ower predictive values.
ISCUSSION
Our data confirms the strong association of CPwith the
linical severity of CVD, as explained by the CEAP “C”
lasses, and shows that among its four components, “stasis
pots” and blue telangiectases are the best predictors for
kin changes of venous origin.
The reliability of these results depends on the condi-
ions of data collection. Therefore, every effort has been
ade to ensure the interobserver reproducibility as much as
ossible through use of reference illustrations and remind-
rs of definitions. We previously tested the reproducibility
sing the same software and found a kappa coefficient of
.51 when testing the interobserver reproducibility of tel-
ngiectases,10 and 0.61 for the corona.11 In any case, poor
eliability would have produced increased variability and
ecreased power of the comparisons, which means that we
re confident about the relevance of the significant results
btained.
Significance of corona. In a previous paper studying a
ifferent series of 874 patients, we found a significant
ssociation of corona7 to clinical severity classes (2: P 
001, Spearman rank correlation coefficient r .28), which
uggested that the corona should not be considered to be
imilar to telangiectases and reticular veins in other loca-
ions.
Althoughwe did not check the distal venous pressure in
he present study, the significant relationship between co-
ona and distal reflux corroborates the hypothesis of Van
er Molen that corona may be consequence of the venous
tasis of the foot,3 related to a prolonged or severe venous
ypertension. This was also the hypothesis described by
ockett12 as the “ankle blow out syndrome,” which was
ore recently supported by the data of the Edinburgh
tudy.13 This is also consistent with the findings of Hirai,14
howing a shortened half filling time measured by photop-
ethysmography in patients with CP.
Robertson et al10 also showed that CP is an indepen-
ent predictor of subsequent ulceration (odds ratio, 4.52;
5% confidence interval, 1.81-11.3).
The corona cannot be seen any more like simple telan-
iectasies of the foot. It is a sign of severe venous stasis,
orrelated with the presence of incompetent perforators of
he leg and has a high predictive value of the onset of skin
hanges.
ONCLUSION
This study shows that only two out of the four CP
omponents are related to the clinical severity of CVD as
xpressed by the CEAP “C” classes: Blue telangiectases and
stasis spots” are strongly related to the clinical severity,
nd even show high predictive values for an advanced CVD
C4-C6), which seems promising for clinical application.
y contrast, “venous cups” and red telangiectases do not
how any clinical significance, and the usefulness of
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needed to reconfirm our findings and to ensure reproduc-
ibility is achieved in the clinical assessment of blue telangi-
ectases and “stasis spots,” which is essential to validate their
use in clinical research and practice.
This work was performed by P. Boivin, N. Berthaux,
Fig 2. Prevalence of the cupular veins and red te
Fig 3. Prevalence of the blue telangiectases according t
.32) and of the stasis spots classes (significant correlation
Table II. Diagnostic value of corona phlebectatica
components for advanced venous insufficiency (CEAP
C4-C6), and rank correlation with “C” classes
Corona components
Likelihood
ratio Sensitivity Specificity
Spearman
rank
correlation
“Stasis spots” 3.83 0.75 0.80 0.39
Blue telangiectases 1.89 0.91 0.52 0.31
“Venous cups” 1.79 0.68 0.65 0.21
Red telangiectases 1.24 0.91 0.27 0.29P.H. Carpentier (study coordinator), F. Chleir, H. deottereau, A. Cornu-Thenard, E. Le Floch, P. Gounon, B.
atger, M. Lefebvre-Vilardebo, J.F. Uhl.
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The advantages of a uniform nomenclature are so obvious that
it is surprising no attempts to develop one for chronic venous
diseases (CVD) were made until the 1990s. Development of the
CEAP by the American Venous Forum (AVF) in 1993 to 1994,
followed by a rapid international acceptance of this classification,
introduced a uniformity of reporting, and the systematic investiga-
tion of CVD commenced.
It soon became clear that what seems to be a simple and
precise description of the signs of venous disorders is a matter of
disagreement and controversy. The original CEAP classification
specified four signs: venous dilation (including telangiectases, and
reticular and varicose veins), edema, skin pigmentation, and ulcer.
Malleolar flare was included in the C1 clinical class. Despite the
perceived clarity of CEAP, analysis of the European Venous Reg-
istry demonstrated significant variability in assigning patients to
the clinical classes. This prompted the international consensus
meeting in Rome in 2001, and refinements of the clinical classifi-
cation, the C in CEAP.1 Additional signs, such as atrophie blanche,
eczema, and lipodermatosclerosis were described and included in
definition of clinical classes. The term “malleolar flair” was re-
placed by a synonym “corona phlebectatica.” Although this sign
was not identified as a criterion for any of the C0-C6 clinical classes,
it was stated that corona phlebectatica is “commonly thought to be
an early sign of advanced venous disease.”
The article by Uhl et al is a further attempt to improve theemonstrated that only two of the four elements of the current
efinition (blue telangiectases and stasis spots) can potentially
erve as markers of the CVD severity. These data support the
uthors’ continuous effort to modify the CEAP classification to
nclude corona phlebectatica in the C4 clinical class.
Knowing that CEAP, however imperfect, already serves its
urpose, one may wonder how much improvement it needs and
ow much of the change is reasonable. After all, CEAP is an
mpiric descriptive classification and, as such, may be replaced in
he future by a more accurate system reflecting specific underlying
athologic processes and mechanisms. Acquiring this knowledge,
owever, requires consistency, and changes in classification may
eopardize the results of the 15-year progress resulted from cre-
tion and adaption of CEAP.
A remarkable aspect of this publication is that at the time when
n-depth investigation of disease processes at all levels of biologic
rganization—from system to submolecular—became scientific
outine, venous diseases are still at a stage when so much energy is
evoted to issues of descriptive classification. This underlines a
reater problem of lack in knowledge of basic physiological and
athologic mechanisms involved.
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